Navigation Links
Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
Date:6/26/2012

STATESVILLE, N.C., June 26, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its fourth quarter and year ended April 30, 2012.

Fourth Quarter Results

Net earnings for the fourth quarter were $1,256,000, or $0.49 per diluted share, up from net earnings of $252,000, or $0.10 per diluted share, in the same period of the prior year.  Earnings for the quarter benefited from strong international operations sales and earnings, while domestic operations earnings benefited from lower operating costs resulting from cost savings initiatives commenced earlier in the year.

Sales for the quarter were $28,990,000, up 8% from sales of $26,952,000 in the same period of the prior year. Sales from domestic operations were $19,607,000, down 10% from sales of $21,797,000 in the prior year. However, incoming domestic orders for the quarter increased 22% over the same quarter last year. Sales from international operations increased to $9,383,000, up 82% from sales of $5,155,000 in the same period of the prior year, as the Company began manufacturing and shipping products for several large projects in its order backlog.

The order backlog increased to a record $86.2 million at April 30, 2012, up from $65.7 million at April 30, 2011, with both domestic and international orders contributing to the growth. The backlog at April 30, 2012 includes a contract awarded during the quarter for laboratory furniture and equipment for the Kuwait University College of Engineering and Petroleum-Women's Campus. The contract, which is in excess of $11 million, was awarded through Kewaunee's dealer in Kuwait, Advanced Technology Company (ATC). The Company expects to begin manufacturing and shipping products under the contract in the late summer or early fall of calendar year 2013. The majority of the manufactured products will be produced at the Company's Statesville facilities. This contract is another indication of the Company's increased international presence and capabilities.

"We are very pleased with our operating results for the quarter," said William A. Shumaker, Kewaunee's Chief Executive Officer. "Our international operations had an outstanding quarter for sales and earnings, as manufacturing and shipping occurred under several large contracts. In Statesville, earnings improved significantly, as we experienced lower operating costs resulting from cost savings initiatives."

Fiscal Year 2012 Results

Sales for the year were $102,847,000, up 3% from sales of $100,003,000 in the prior year. Sales from domestic operations were $83,971,000, as compared to sales of $84,121,000 in the prior year. The domestic marketplace for privately-funded projects held up relatively well during the year, although at extremely competitive prices, while opportunities and orders for publicly-funded K-12 educational projects, primarily wood furniture, dropped sharply in the second quarter of the year and have continued to remain at historically low levels. Sales from international operations increased to $18,876,000, up 19% from sales of $15,882,000 in the prior year.

Net earnings for the year were $1,031,000, or $0.40 per diluted share, down from net earnings of $1,850,000, or $0.72 per diluted share, in the prior year. Earnings for the year were unfavorably impacted by lower selling prices, a significant increase in raw material costs beginning early in the year, particularly for steel and epoxy resin, and a large drop-off in demand for wood furniture projects. Earnings for the year were favorably impacted by strong international sales and earnings in the second half of the year, particularly the fourth quarter, and lower operating costs resulting from headcount reductions and other cost savings initiatives at Statesville.

The Company's balance sheet and financial condition remain strong.  Cash on hand at the end of the year was $6.9 million, as compared to $3.0 million at the end of the prior year. Working capital increased to $23.4 million at April 30, 2012, up from $22.1 million at the end of the prior year.  Short term borrowings under the Company's $15 million bank line of credit were $6.8 million, as compared to $6.6 million at the end of the prior year, and total bank borrowings and capital lease obligations were $10.5 million, as compared to $10.6 million at the end of the prior year. The debt-to-equity ratio was .36-to-1 at year-end, as compared to .34-to-1 at the end of the prior year.

Outlook

"Looking forward to fiscal year 2013, I remain cautiously optimistic," Mr. Shumaker continued. "My optimism is based on a number of factors. On the domestic front, we enter the year with a strengthened and expanded dealer network, which we believe will result in increased sales and earnings. We are also realizing lower operating costs from our cost savings initiatives put in place over the past year. On the international front, we have also strengthened and expanded our dealer network, better positioning us to take advantage of the growing number of laboratory project opportunities in Asia and the Middle East. Furthermore, both domestic and international operations will benefit from our record order backlog.

"At the same time, fiscal year 2013 will present us with significant challenges. The ongoing world-wide economic slowdown continues to depress construction activity and pricing in the marketplace. Customer delivery requirements for large international projects, more so than domestic projects, often are delayed due to changes in construction schedules, resulting in uneven reportable sales and earnings."

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, systems, and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems, and stand-alone benches.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.Consolidated Statements of Operations
(in thousands, except per share data)Three Months Ended

Years EndedApril 30

April 302012

2011

2012

2011(Unaudited)Net sales$28,990

$26,952

$102,847

$100,003Cost of products sold21,638

22,247

83,691

80,719Gross profit7,352

4,705

19,156

19,284Operating expenses4,493

4,174

16,443

16,127Operating earnings2,859

531

2,713

3,157Other income (expense)43

4

271

4Interest expense(112)

(94)

(445)

(199)Earnings before income taxes2,790

441

2,539

2,962Income tax expense976

72

739

864Net earnings1,814

369

1,800

2,098Less:  net earnings attributable to the
noncontrolling interest558

117

769

248Net earnings attributable to 
Kewaunee Scientific Corporation$1,256

$252

$1,031

$1,850Net earnings per share attributable to
Kewaunee Scientific Corporation stockholdersBasic$0.49

$0.10

$0.40

$0.72Diluted$0.49

$0.10

$0.40

$0.72Weighted average number of common 
shares outstanding (in thousands)Basic2,579

2,578

2,579

2,575Diluted2,580

2,593

2,580

2,585 Condensed Consolidated Balance Sheets(in thousands)April 30

April 302012

2011AssetsCash and cash equivalents

$6,188

$2,402Restricted cash

704

553Receivables, less allowances

23,244

27,346Inventories

11,760

10,466Prepaid expenses and other current assets

1,702

1,612Total current assets

43,598

42,379Net property, plant and equipment

15,346

16,575Other assets

5,192

4,104Total Assets

$64,136

$63,058Liabilities and Stockholders' EquityShort-term borrowings

$6,816

$6,588Current obligations under capital leases

36

83Current portion of long-term debt

200

200Accounts payable

8,848

9,770Other current liabilities

4,340

3,623Total current liabilities

20,240

20,264Other non-current liabilities

12,238

9,778Total liabilities

32,478

30,042Noncontrolling interest

2,147

1,525Kewaunee Scientific Corporation equity

29,511

31,491Total equity

31,658

33,016Total Liabilities and Stockholders' Equity

$64,136

$63,058 

Contact: D. Michael Parker
704/871-3290 


'/>"/>
SOURCE Kewaunee Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accelrys Fast-tracks Scientific Innovation with Modeling and Simulation Software Release
2. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
3. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
4. Boston Scientific Closes Cameron Health Acquisition
5. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
6. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
7. Scripps Research Institutes Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research
8. Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
9. Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
10. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
11. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/27/2016)... Lafayette, California (PRWEB) , ... ... ... a pioneer in the patient payment industry today announced its strategic partnership ... and health system workflows. , The two companies’ proven, proprietary technology combine ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
Breaking Medicine News(10 mins):